ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

Company Zhongzhi Pharmaceutical Holdings Limited

3737

KYG989611085

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:25 16/01/2026 pm IST			5-day change	1st Jan Change
0.7100 ^HKD	-4.05%		-19.32%	+26.79%

26/25/26	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/25/18	Zhongzhi pharmaceutical expects 90% decrease in HY net profit	RE

Business description: Zhongzhi Pharmaceutical Holdings Limited

Zhongzhi Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical products. The Company's products comprise Chinese patent medicines and decoction pieces, mainly consisting of traditional decoction pieces and modern decoction pieces. The Company operates through two segments, including Pharmaceutical Manufacturing segment and Operation of Chain Pharmacies segment. The Company owns brands such as Zhongzhi and Cao Jinghua. The Company's product series also comprises PoBiCaoBen and ZhongChengYao. The Company mainly conducts its businesses in the domestic market.

Number of employees: 2,488

Sales by Activity: Zhongzhi Pharmaceutical Holdings Limited

Fiscal Period: December	2020 (CNY)	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)
Pharmaceutical Manufacturing	99Cr	187.72Cr	184.79Cr	211.19Cr	233.25Cr
Operation of Chain Pharmacies	-	-	70Cr	63Cr	59Cr
Operation of Chain Pharmacies (Excl. Operation of On-Line Pharmacies)	62Cr	62Cr	-	-	-
Elimination of Intersegment Sales	-6.95Cr	-82Cr	-72Cr	-70Cr	-71Cr
Operation of On-Line Pharmacies	6.29Cr	7.03Cr	-	-	-

See all business segments

Geographical breakdown of sales: Zhongzhi Pharmaceutical Holdings Limited

Fiscal Period: December	2020 (CNY)	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)
Mainland China	160.39Cr	174.65Cr	182.59Cr	204.98Cr	221.48Cr

See all geographic segments

Executive Committee: Zhongzhi Pharmaceutical Holdings Limited

Manager	Title	Age	Since
Ying Feng Lai CEO	Chief Executive Officer	34	24/03/2021
Ying Sheng Lai DFI	Director of Finance/CFO	33	24/03/2021
Wing Yan Ho SEC	Corporate Secretary	44	05/05/2017

See ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED governance

Composition of the Board of Directors: Zhongzhi Pharmaceutical Holdings Limited

Director	Title	Age	Since
Zhi Tian Lai CHM	Chairman	59	12/09/2014
Li Xia Jiang BRD	Director/Board Member	61	12/09/2014
Xiao Jun Cao BRD	Director/Board Member	59	30/01/2015
Kwun Wan Ng BRD	Director/Board Member	62	08/06/2015
Dai Han Zhou BRD	Director/Board Member	84	08/06/2015
Ying Feng Lai BRD	Director/Board Member	34	14/05/2018
Ying Sheng Lai BRD	Director/Board Member	33	24/03/2022

Composition of the Board of Directors

Shareholders: Zhongzhi Pharmaceutical Holdings Limited

Name	Equities	%	Valuation
Zhi Tian Lai 60.47 %	52,22,07,800	60.47 %	38 M $
Li Xia Jiang 4.891 %	4,22,40,000	4.891 %	3 M $
Ying Feng Lai 0.6936 %	59,90,000	0.6936 %	430 981 $
Xiao Jun Cao 0.375 %	32,38,600	0.375 %	233 017 $
Zhi Yun Peng 0.1425 %	12,31,000	0.1425 %	88 570 $

List of ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED shareholders

Company details: Zhongzhi Pharmaceutical Holdings Limited

Zhongzhi Pharmaceutical Holdings Ltd.

No. 3 Kangtai Road South

528437, Zhongshan

http://www.zeus.cn

address Zhongzhi Pharmaceutical Holdings Limited(3737)

Generic Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED	-4.05%	-19.32%	-29.70%	-36.04%	7.86Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	-1.87%	-3.53%	-6.59%	+61.61%	4.41TCr
SANDOZ GROUP AG	+1.97%	+2.51%	+52.27%	-	3.33TCr
OTSUKA HOLDINGS CO., LTD.	-2.07%	-0.83%	+13.23%	+121.06%	3.01TCr
CIPLA LIMITED	-2.58%	-4.65%	-3.11%	+30.72%	1.24TCr
ZYDUS LIFESCIENCES LIMITED	-1.77%	-2.99%	-12.72%	+101.21%	962.73Cr
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-0.68%	-3.97%	+73.06%	+46.33%	839.78Cr
KRKA, D. D.	+0.91%	+3.27%	+48.82%	+129.73%	780.96Cr
THE MEDICINES COMPANY	-.--%	+0.14%	-	-	678.76Cr
ONO PHARMACEUTICAL CO., LTD.	-0.77%	-0.53%	+39.62%	-20.21%	672.15Cr
Average	-1.09%	-2.95%	+19.43%	+54.30%	1.59TCr
Weighted average by Cap.	-0.83%	-1.20%	+19.30%	+75.30%